Literature DB >> 10517190

Prognostic factors influencing mortality in cancer patients with neutropenia and bacteremia.

E González-Barca1, A Fernández-Sevilla, J Carratalá, A Salar, J Peris, A Grañena, F Gudiol.   

Abstract

The purpose of this study was to identify risk factors for mortality in neutropenic patients with cancer and bacteremia. A consecutive sample of 438 neutropenic patients (granulocyte count <0.5 x 10(9)/l) with cancer and bacteremia was studied to identify the clinical characteristics associated with mortality at the onset of bacteremia. The mean age of the subjects was 48 years (range, 15-87 years). Most cases of bacteremia (77%) were hospital-acquired and occurred in patients with acute leukemia (48%). Gram-positive organisms caused 233 (53%) episodes of bacteremia, gram-negative organisms caused 151 (34%) episodes, and 48 (11%) episodes were polymicrobial. The overall mortality within 30 days of the onset of bacteremia was 24.4%. The variables found to be independently associated with increased mortality using logistic regression techniques were as follows: shock at the onset of bacteremia (OR, 10; 95% CI, 4.2-23.8), pneumonia (OR,4.4; 95% CI, 1.9-10), uncontrolled cancer (OR,4.3; 95% CI, 1.5-12.7), and absence of prophylaxis with norfloxacin (OR,2.4; 95% CI, 1.3-4.5). The prognostic factors ascertained in this study may help to identify those patients at higher risk of death. Medical intervention addressing some of these factors may improve the outcome of bacteremia in neutropenic patients with cancer.

Entities:  

Mesh:

Year:  1999        PMID: 10517190     DOI: 10.1007/s100960050345

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  23 in total

1.  Impact of time to antibiotic on hospital stay, intensive care unit admission, and mortality in febrile neutropenia.

Authors:  Lisa M Daniels; Urshila Durani; Jason N Barreto; John C O'Horo; Mustaqeem A Siddiqui; John G Park; Pritish K Tosh
Journal:  Support Care Cancer       Date:  2019-02-25       Impact factor: 3.603

2.  Epidemiology, antibiotic therapy and outcomes of bacteremia caused by drug-resistant ESKAPE pathogens in cancer patients.

Authors:  Marta Bodro; Carlota Gudiol; Carolina Garcia-Vidal; Fe Tubau; Anna Contra; Lucía Boix; Eva Domingo-Domenech; Mariona Calvo; Jordi Carratalà
Journal:  Support Care Cancer       Date:  2013-10-30       Impact factor: 3.603

3.  Personalized medicine and cancer supportive care: appropriate use of colony-stimulating factor support of chemotherapy.

Authors:  Nicole M Kuderer; Gary H Lyman
Journal:  J Natl Cancer Inst       Date:  2011-06-13       Impact factor: 13.506

4.  Protocol for Reducing Time to Antibiotics in Pediatric Patients Presenting to an Emergency Department With Fever and Neutropenia: Efficacy and Barriers.

Authors:  Clay Cohen; Amber King; Chee Paul Lin; Gregory K Friedman; Kathy Monroe; Matthew Kutny
Journal:  Pediatr Emerg Care       Date:  2016-11       Impact factor: 1.454

5.  Role of interleukin-6 in differentiating interleukin-11 induced fever and early bacterial infection.

Authors:  Juan Liang; Zhiyu Lei; Xiaojun Xu; Ning Zhao; Hua Song; Shilong Yang; Fenying Zhao; Junqing Mao; Chan Liao; Diying Shen; Yongmin Tang
Journal:  Indian J Pediatr       Date:  2014-03-28       Impact factor: 1.967

6.  European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia.

Authors:  Diana Averbuch; Christina Orasch; Catherine Cordonnier; David M Livermore; Malgorzata Mikulska; Claudio Viscoli; Inge C Gyssens; Winfried V Kern; Galina Klyasova; Oscar Marchetti; Dan Engelhard; Murat Akova
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

7.  Prospective evaluation of the epidemiology, microbiology, and outcome of bloodstream infections in hematologic patients in a single cancer center.

Authors:  E Velasco; R Byington; C A S Martins; M Schirmer; L M C Dias; V M S C Gonçalves
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-03-05       Impact factor: 3.267

8.  Infection Probability Score, APACHE II and KARNOFSKY scoring systems as predictors of bloodstream infection onset in hematology-oncology patients.

Authors:  Eleni Apostolopoulou; Vasilios Raftopoulos; Konstantinos Terzis; Ioannis Elefsiniotis
Journal:  BMC Infect Dis       Date:  2010-05-26       Impact factor: 3.090

9.  Delay of active antimicrobial therapy and mortality among patients with bacteremia: impact of severe neutropenia.

Authors:  Michael Y Lin; Robert A Weinstein; Bala Hota
Journal:  Antimicrob Agents Chemother       Date:  2008-07-14       Impact factor: 5.191

10.  Prognostic factors and scoring model of hematological malignancies patients with bloodstream infections.

Authors:  Yishu Tang; Qian Cheng; Qing Yang; Jing Liu; Di Zhang; Wei Cao; Qingxia Liu; Tianyi Zhou; Huiqi Zeng; Li Zhou; QinJin Wang; Huan Wei; Xin Li
Journal:  Infection       Date:  2018-05-16       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.